Lessee, Operating Lease, Liability, to be Paid, Year Two in USD of Bionik Laboratories Corp. from Q3 2022 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Bionik Laboratories Corp. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and change rate from Q3 2022 to Q1 2023.
  • Bionik Laboratories Corp. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 31 Mar 2023 was $38,202.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)

Bionik Laboratories Corp. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $38,202 31 Mar 2023 10-K 21 Jun 2023 2023 FY
Q4 2022 $38,202 31 Dec 2022 10-Q 08 Feb 2023 2023 Q3
Q3 2022 $38,202 30 Sep 2022 10-Q 09 Nov 2022 2023 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.